OBJECTIVE: Recent study by Morris JM et al. (Lancet 2016; 387: 444-52) demonstrated that in the absence of overt signs of infection or fetal compromise, expectant management, but not immediate delivery, should be followed in late preterm PROM contrary to the recommendation by ACOG (#172, 2016) . However, the presence or absence of amniotic fluid (AF) and placental inflammation, which are critical to the pregnancy outcomes in PROM, was not examined in that study. Up to now, there is no information about whether prolonged latency to delivery is associated with an increased frequency of placental inflammation according to the presence or absence of AF inflammation in the context of early preterm (< 34 wks) or late preterm (34w37 wks) PROM. The objective of the study is to examine this issue. STUDY DESIGN: Study population included 352 singleton pregnant women who were admitted with the diagnosis of preterm-PROM and had an amniocentesis. The frequency of placental inflammation was compared between "amniocentesis-to-delivery interval (ATDI) ! 3 days" and "ATDI < 3 days" groups according to sterile or inflammatory/infectious AF in the context of early (n¼210) or late (n¼142) preterm-PROM. Placental inflammation was divided into inflammation restricted to chorio-decidua (CD) and inflammation beyond CD. Inflammation restricted to CD and inflammation beyond CD were defined by the previously published criteria. Sterile AF was defined as a negative culture and the absence of inflammation as evidenced by a MMP-8 level < 23 ng/ml in AF. Inflammatory/infectious AF was defined in the presence of either AF inflammation or a positive AF culture. RESULTS: 1) Sterile AF was present in 52% (109/210) of early preterm-PROM and 83% (118/142) of late preterm-PROM; 2) The frequency of placental inflammation was significantly more increased in "ATDI ! 3 days" groups than in "ATDI < 3 days" groups in the context of late preterm, but not early preterm, PROM with sterile AF (Fig. 1) ; 3) However, the frequency of placental inflammation was not different between "ATDI ! 3 days" and "ATDI < 3 days" groups in the context of both early and late preterm-PROM with inflammatory/infectious AF (Fig. 2) . CONCLUSION: Three or more days of prolonged latency to delivery is associated with an increased frequency of placental inflammation in the context of late preterm, but not early preterm, PROM with sterile AF. This finding may be evidence to suggest that immediate delivery should be recommended in late preterm-PROM as previously. OBJECTIVE: The objective of this study was to determine the incidence of neonatal respiratory morbidity in infants born at 34-36 weeks gestation since the implementation of late preterm corticosteroid administration. STUDY DESIGN: A retrospective cohort study was performed on patients who delivered between 1/1/2015 and 4/24/2018 at a single institution. The study group included women who received 2 doses of 12 mg IM betamethasone 24 hours apart between 34/0 and 36/6 weeks. A historical cohort consisted of patients who delivered between 34/0 and 36/6 who did not receive betamethasone. Primary outcomes included a composite of respiratory treatment (rates of neonates requiring respiratory support in first 72 hours after delivery including continuous positive airway pressure (CPAP) or nasal cannula for at least 2 hours, supplemental oxygen with fraction of inspired oxygen of at least 0.30 for at least 4 hours, mechanical ventilation) and the rates of neonatal hypoglycemia (<44 mg/dL).
Poster Session III RESULTS: A total of 376 patients were included e 121 patients who received late preterm steroids and 255 patients who served as a historical control. Preliminary data demonstrates no statistically significant differences in maternal demographics. A statistically significant difference in birthweight was initially noted between the groups (p < 0.001) however when controlled for there was no difference (p ¼ 0.206).
Initially, there was no statistically significant difference between the groups of neonates requiring respiratory treatment in the first 72 hours (p ¼ 0.069), however, results became statistically significant when birthweight was controlled (p ¼ 0.045). Neonates within the betamethasone group had higher rates of hypoglycemia compared to the control group (p ¼ 0.012). The significance was retained even after controlling for the birthweight (p ¼ 0.007). OBJECTIVE: Premature cervical remodeling is likely an obligatory step in the pathogenesis of spontaneous preterm birth. Previously, we have shown Replens, the vehicle used to deliver vaginal progesterone, will prevent preterm birth in an inflammatory mouse model. However, it remains unknown if Replens will have an impact on cervical remodeling. Therefore, we hypothesize Replens will prevent preterm birth and cervical remodeling by inhibiting the inflammation induced functional changes to the cervical epithelial barrier. STUDY DESIGN: The integrity of the epithelial cell barrier was assessed using an in vitro permeability assay. Immortalized ectocervical cells were grown in a monolayer across a semi permeable membrane at a concentration of 2 x 10 5 cells well. Cells were treated with 10% and 25% solutions of Replens in saline for 2 hours prior to treatment with 25ug/ml of lipopolysaccharide (LPS). After 24 hours, FITCdextran was added for 2 hours. The extent of permeability was determined by measuring the fluorescence on the receiver plates well solution. RESULTS: Exposure to LPS alone significantly increased the permeability of ectocervical cells (p<0.05), and pretreatment with Replens prevented the LPS induced increase in permeability at concentrations of 10% (p<0.001) and 25% (p<0.001) compared to treatment with LPS only. CONCLUSION: These studies demonstrate Replens prevents the LPS induced breakdown of the ectocervical epithelial barrier. Further research is needed to determine if Replens can be utilized as a therapeutic agent to prevent preterm birth.
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